ALKYLAMINE — Alkyl Amines Chemicals Balance Sheet
0.000.00%
- IN₹87.96bn
- IN₹85.42bn
- IN₹15.36bn
Annual balance sheet for Alkyl Amines Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 615 | 172 | 304 | 2,028 | 2,556 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 3,054 | 2,886 | 2,308 | 2,519 | 2,306 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,376 | 5,006 | 4,434 | 6,301 | 6,728 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,698 | 10,676 | 11,211 | 10,933 | 11,427 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 13,713 | 15,919 | 15,836 | 17,889 | 18,954 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3,279 | 3,542 | 2,279 | 2,452 | 2,159 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,815 | 4,230 | 3,165 | 3,864 | 3,620 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 9,898 | 11,689 | 12,671 | 14,025 | 15,334 |
| Total Liabilities & Shareholders' Equity | 13,713 | 15,919 | 15,836 | 17,889 | 18,954 |
| Total Common Shares Outstanding |